Vogt-Koyanagi-Harada Disease, Diabetes Mellitus, and Psoriasis in a Child

Purpose: To report a case of a child with near-simultaneous onset of Vogt Koyanagi Harada disease (VKH) and insulin-dependent diabetes mellitus (IDDM). Design: Interventional case report. Methods: An 11-year-old child with known psoriasis presented with headache and bilateral granulomatous panuveitis. Nine weeks later, he presented with diabetic ketoacidosis and IDDM. Diffuse choroidal depigmentation followed within months. HLA was positive for DRB1*0405. Despite aggressive local and systemic therapy, the ocular disease was complicated by bilateral cataracts, angle closure glaucoma, and choroidal neovascularization. Results: The patient is currently pseudophakic in one eye and aphakic in the other, with best-corrected visual acuity of 6/24 and 6/5, respectively. Conclusions: VKH may present in children with panuveitis in the setting of other autoimmune disorders. Treating such patients is complicated by the need to minimize systemic corticosteroid use. A combination of local therapy and systemic steroid-sparing agents should be the mainstay of treatment.

[1]  I. Hamade,et al.  The association of systemic disorders with Vogt–Koyanagi–Harada and sympathetic ophthalmia , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  J. Schiffman,et al.  Bevacizumab in inflammatory eye disease. , 2009, American journal of ophthalmology.

[3]  R. Avery.  Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concern. , 2009, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[4]  M. Çakır,et al.  Intravitreal bevacizumab for idiopathic choroidal neovascularization. , 2009, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[5]  M. Çakır,et al.  Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease. , 2009, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[6]  T. Morio,et al.  Bilateral Anterior Granulomatous Keratouveitis with Sunset Glow Fundus in a Patient with Autoimmune Polyglandular Syndrome , 2009, Ocular immunology and inflammation.

[7]  F. Paç,et al.  Glucocorticoid-induced Diabetic Ketoacidosis in Acute Rheumatic Fever , 2008, Journal of cardiovascular pharmacology and therapeutics.

[8]  M. Çakır,et al.  Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease. , 2008, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[9]  B. Guillot,et al.  Vogt-koyanagi-harada syndrome associated with psoriasis and autoimmune thyroid disease. , 2008, Acta dermato-venereologica.

[10]  Hiroaki Suzuki,et al.  Type 1 diabetes mellitus associated with Graves' disease and Vogt-Koyanagi-Harada syndrome. , 2008, Internal medicine.

[11]  Sheri L. Riccardi,et al.  NALP1 in vitiligo-associated multiple autoimmune disease. , 2007, The New England journal of medicine.

[12]  C. Gorodezky,et al.  HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example. , 2006, Autoimmunity reviews.

[13]  K. Tabbara,et al.  Vogt-Koyanagi-Harada Associated with Diabetes Mellitus and Celiac Disease in a 3-Year-Old Girl , 2006, European journal of ophthalmology.

[14]  W. Klitz,et al.  The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. , 2002, Tissue antigens.

[15]  H. Hayashi,et al.  A Case of Insulin Dependent Diabetes Mellitus Following Systemic Treatment with Corticosteroids for Vogt-Koyanagi-Harada Syndrome , 2000 .

[16]  G. Peyman,et al.  Intravitreal tPA and SF6 promote clearing of premacular subhyaloid hemorrhages in shaken and battered baby syndrome. , 1999, Ophthalmic surgery and lasers.

[17]  I. Süveges,et al.  Vogt‐Koyanagi‐Harada syndrome , 1993, Acta ophthalmologica.